AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16135679
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of inhaled corticosteroids (ICS)
Trial: 12431824
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with gemcitabine/cisplatin
Trial: 10598596
Drug: 1.5 l
RxNorm normalized name: NUTREN 1.5 LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 l lactated Ringer's solution (LR)
Trial: 10598596
Drug: 0.5 l
RxNorm normalized name: AIR 20.5 L in 100 L RESPIRATORY (INHALATION) GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 l hydroxyethylstarch solution, 6% (0.5 l HES)
Trial: 10598596
Drug: 1.0 l
RxNorm normalized name: NUTREN 1.0 LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 l hydroxyethylstarch solution, 6% (1.0 l HES)
Trial: 1747702
Drug: Hydroxychloroquine 400
RxNorm normalized name: hydroxychloroquine 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine 400 mg daily
Trial: 25398660
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n=29)
Trial: 24226495
Drug: Unilateral spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral spinal anesthesia with 50 mg hyperbaric prilocaine 2%
Trial: 24226495
Drug: Bilateral spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral spinal anesthesia with 50 mg hyperbaric prilocaine 2%
Trial: 20014597
Drug: Low-dose ropivacaine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ropivacaine (0.2%)
Trial: 20014597
Drug: High-dose ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ropivacaine (0.375%)
Trial: 17303970
Drug: MK-0703 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0703 12.5 mg
Trial: 17303970
Drug: MK-0703 50
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0703 50 mg
Trial: 17303970
Drug: MK-0703 100
RxNorm normalized name: vitamin MK 7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0703 100 mg
Trial: 11097697
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (75 mg/kg, maximum 2.5 g)
Trial: 3835497
Drug: Piracetam (800‐6,400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam (800‐6,400 mg)
Trial: 3835497
Drug: Piracetam-lecithin (4,800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam-lecithin (4,800 mg and 25 g, respectively)
Trial: 7916551
Drug: Vecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.1 mg.kg‐1
Trial: 31626219
Drug: Aripiprazole at
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole at a dose of up to 20 mg/day
Trial: 31626219
Drug: Quetiapine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine at a dose of up to 600 mg/day
Trial: 31626219
Drug: Haloperidol at
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol at a dose of up to 30 mg/day
Trial: 23238778
Drug: Mosapride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride (5 mg, 3/day)
Trial: 23238778
Drug: Lansoprazole (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (15 mg, 1/day)
Trial: 23238778
Drug: Control (without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (without medication)
Trial: 21560152
Drug: Intravesical injections
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical injections of 100 U of onabotulinumtoxinA into bladder body
Trial: 21560152
Drug: Intravesical injections
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical injections of 100 U of onabotulinumtoxinA into bladder body/trigone
Trial: 21560152
Drug: Intravesical injections
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical injections of 100 U of onabotulinumtoxinA into bladder base/trigone
Trial: 1357450
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (calcium-channel-blocking drug plus aspirin)
Trial: 4013624
Drug: Droperidol (0.014
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (0.014 mg/kg)
Trial: 19489492
Drug: Chuzhen therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chuzhen therapy
Trial: 20931060
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation plus oral rehydration salts (ORS)
Trial: 18816596
Drug: Dexamethasone 6
RxNorm normalized name: dexamethasone 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 6 mg administered intravenously intraoperatively (Arm A)
Trial: 18816596
Drug: No steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No steroids (Arm B)
Trial: 11028549
Drug: Topical antimicrobials
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antimicrobials and dressing changes
Trial: 8761540
Drug: Low-calcium dialysate
RxNorm normalized name: Dianeal Low Calcium 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-calcium dialysate solution (LCa, 1.0 mmol/L)
Trial: 8761540
Drug: Standard-calcium dialysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-calcium dialysate solution (SCa, 1.75 mmol/L)
Trial: 8761540
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (CaCO3) as oral phosphate binder
Trial: 1550410
Drug: Lornoxicam 6
RxNorm normalized name: lornoxicam
DrugBank: Lornoxicam (DB06725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 6 mg once daily
Trial: 1550410
Drug: Lornoxicam 8
RxNorm normalized name: lornoxicam 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 8 mg twice daily
Trial: 1550410
Drug: Lornoxicam 12
RxNorm normalized name: lornoxicam
DrugBank: Lornoxicam (DB06725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 12 mg twice daily
Trial: 1550410
Drug: Lornoxicam 8
RxNorm normalized name: lornoxicam 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 8 mg daily
Trial: 27070534
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight hyaluronic acid (LMW‐HA) injection (Hyalgan®, 500‐730 kDa), 3 injections
Trial: 27070534
Drug: Low-energy extracorporeal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-energy extracorporeal shock-wave therapy (ESWT), 4 sessions
Trial: 26122244
Drug: Melatonin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (0.5 mg/kg BW, max 5 mg)
Trial: 23740007
Drug: Miltefosine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miltefosine (50 mg three times per day for 28 days)
Trial: 18435392
Drug: One Arm
RxNorm normalized name: humanized immunoglobulin G1-kappa anti-(human B-lymphocyte antigen CD19) modified heterodimer where the heavy and light chain variable regions of one arm have been substituted by three subunits of human 4- 1BB ligand (tumor necrosis factor ligand superfa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One Arm Group (both vaccines in one arm)
Trial: 18435392
Drug: Two Arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two Arm Group (one vaccine in each arm)
Trial: 12511765
Drug: Antidepressive medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressive medication (exact dosage and duration not specified)
Trial: 10682151
Drug: Zidovudine/lamivudine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine/lamivudine combination therapy
Trial: 7027040
Drug: Dialysis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis treatment time (long or short)
Trial: 28495391
Drug: Embodied Conversational
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Embodied Conversational Agent (ECA)
Trial: 25716637
Drug: Vitamin D2
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin D2 (50,000 IU weekly)
Trial: 24016557
Drug: Type A
RxNorm normalized name: HLA type A IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type A treatment
Trial: 24016557
Drug: Type B
RxNorm normalized name: HLA type B IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type B treatment
Trial: 24016557
Drug: Type C
RxNorm normalized name: HLA type C IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type C treatment
Trial: 24016557
Drug: Type D
RxNorm normalized name: HLA II type DQ IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Type D treatment
Trial: 24016557
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Glucocorticoid)
Trial: 18087552
Drug: Verapamil (480
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (480 mg/d)
Trial: 18087552
Drug: Metoprolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (50 mg/d)
Trial: 15476904
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 20 mg once daily for 12 months
Trial: 9272793
Drug: Ketamine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.15 mg/kg
Trial: 9916610
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate ophthalmic gel-forming solution 0.5% QD
Trial: 1606348
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg intravenous ciprofloxacin
Trial: 27935735
Drug: Lisdexamfetamine (LDX)
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine (LDX) 70 mg/day for 5 weeks
Trial: 21952094
Drug: IFNβ‐1b 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNβ‐1b 250 µg
Trial: 21952094
Drug: IFNβ‐1b 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNβ‐1b 500 µg
Trial: 21952094
Drug: IFNβ‐1b 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNβ‐1b 250 µg and 500 µg
Trial: 21952094
Drug: Control (Glatiramer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Glatiramer acetate 20 mg)
Trial: 19254906
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (400 microg/day)
Trial: 25672894
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide and Placebo
Trial: 18091071
Drug: Bromocriptine (dopamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (dopamine agonist)
Trial: 15302228
Drug: 35 mg
RxNorm normalized name: papain 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg beta‐methyl‐6‐chloromelatonin
Trial: 15302228
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of beta‐methyl‐6‐chloromelatonin
Trial: 10958716
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg sildenafil
Trial: 10223498
Drug: sildenafil (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sildenafil (all doses)
Trial: 7851353
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release metoclopramide (Gastromax 30 mg)
Trial: 2520372
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid treatment under occlusive dressings for 72 hours
Trial: 17894041
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose thiothixene (40 mg.)
Trial: 17894041
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose thiothixene (10 mg.)
Trial: 26069137
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg (Group A)
Trial: 26069137
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 mg (Group B)
Trial: 16857887
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of micronized progesterone vaginally (progesterone group)
Trial: 16857887
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of micronized progesterone and 4 mg of E2 valerate orally (progesterone/E2 group)
Trial: 9283776
Drug: Extended insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended insulin regimen (5 U/h continued until resolution of hyperketonemia)
Trial: 9283776
Drug: Extended insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended insulin regimen
Trial: 9283776
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin regimen (5 U/h until near-normoglycemia, then reduced rate)
Trial: 3051043
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel (1 mg initial dose, followed by 1 mg or 2 mg 6 hours later if needed)
Trial: 3051043
Drug: Intravenous perfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous perfusion of synthetic oxytocin (starting at 1 mU/min, increased every 20 minutes)
Trial: 24443001
Drug: 3×1000 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3×1000 mg rituximab
Trial: 22921855
Drug: Terlipressin (TP)
DrugBank: Terlipressin (DB02638)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (TP) administered as a continuous intravenous dose of 1.3 μg/kg/h
Trial: 22921855
Drug: Dopamine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine administered in doses up to 20 μg/kg/min
Trial: 21399391
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg CoQ10 daily
Trial: 19615314
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine plus American ginseng and Salviae miltiorrhizae preparations
Trial: 12883913
Drug: Heparin surface-modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin surface-modified polymethylmethacrylate IOL (Pharmacia & Upjohn 809C)
Trial: 9068769
Drug: Amisulpride (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (100 mg/day)
Trial: 20935692
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac (n = 9)
Trial: 20935692
Drug: Topical ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketorolac (n = 11)
Trial: 20935692
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac (n = 8)
Trial: 20935692
Drug: Topical ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketorolac (n = 9)
Trial: 17785764
Drug: Panitumumab 6
RxNorm normalized name: Panitumumab
DrugBank: Panitumumab (DB01269)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Panitumumab 6 mg/kg every 2 weeks
Trial: 20395618
Drug: donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: donepezil 5 mg/d
Trial: 21612646
Drug: donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: donepezil 10 mg/d
Trial: 10994000
Drug: Acetyl-l-carnitine (ALCAR)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-l-carnitine (ALCAR) 1 g tid
Trial: 6303209
Drug: Cefmenoxime (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefmenoxime (1.0 g)
Trial: 6303209
Drug: Procaine penicillin
RxNorm normalized name: procaine penicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaine penicillin G (4.8 X 10(6) U) + probenecid (1.0 g orally)
Trial: 30235387
Drug: Sarecycline 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarecycline 1.5 mg/kg/day
Trial: 20008620
Drug: Dasatinib 50
RxNorm normalized name: dasatinib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasatinib 50 mg twice daily
Trial: 21455450
Drug: Agnikarma (cauterization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agnikarma (cauterization treatment)
Trial: 7880187
Drug: Prednisone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (15 mg/day for 1 month, tapered thereafter)
Trial: 2120362
Drug: Conventional mandibular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional mandibular block injection technique
Trial: 2120362
Drug: Closed-mouth mandibular
RxNorm normalized name: moth bean extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed-mouth mandibular block injection technique
Trial: 23375406
Drug: Granisetron (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (1 mg twice daily)
Trial: 21991733
Drug: Dexmedetomidine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.5 microg/kg in 20 mL saline
Trial: 21991733
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution 20 mL
Trial: 15388819
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein diet (NPD) (1.20+/‐0.06 g/kg/day)
Trial: 15388819
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (LPD) (0.66+/‐0.04 g/kg/day)
Trial: 11352441
Drug: ranitidine 150mg
RxNorm normalized name: GoodSense Ranitidine 150mg Tablet
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranitidine 150mg twice daily during a 3‐day pretreatment phase and 1 tablet of ranitidine with a single 400mg dose of moxifloxacin
Trial: 9398108
Drug: Carteolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carteolol (15 mg/day)
Trial: 3297719
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with Vincristine, Cyclophosphamide, and Prednisone after regional radiotherapy in stage I
Trial: 3297719
Drug: 8 courses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 courses of chemotherapy with Adriamycin, VM26, Cyclophosphamide, and Prednisone in stage III and IV
Trial: 26729347
Drug: Progressive-resisted exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive-resisted exercise (PRE) intervention conducted twice weekly for 12 weeks
Trial: 22366878
Drug: Usual daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual daily activities (Control group)
Trial: 25472808
Drug: Transversus abdominis
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transversus abdominis plane block with ropivacaine 0.375% plus postoperative patient-controlled intravenous analgesia with morphine (TAP group, n = 50)
Trial: 25472808
Drug: Perioperative intravenous
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perioperative intravenous lidocaine plus postoperative patient-controlled intravenous analgesia with morphine (LIDO group, n = 50)
Trial: 25472808
Drug: Postoperative patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative patient-controlled intravenous analgesia with morphine (control group, n = 25)
Trial: 20467151
Drug: Pitavastatin or
RxNorm normalized name: pitavastatin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin or Atorvastatin
Trial: 18936764
Drug: DAG oil
RxNorm normalized name: Daglutril
DrugBank: Daglutril (DB05796)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAG oil (10 g day(-1))
Trial: 18936764
Drug: TAG oil
RxNorm normalized name: ProVent SKIN TAG OIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAG oil (10 g day(-1))
Trial: 8723457
Drug: Ciprofloxacin 400
RxNorm normalized name: ciprofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 400 mg i.v. every 8 h
Trial: 8723457
Drug: Ciprofloxacin 400
RxNorm normalized name: ciprofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 400 mg i.v. every 12 h
Trial: 30226339
Drug: EVE group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVE group: 5 mg of 0.5% isobaric bupivacaine plus 15 Âµg of fentanyl injection followed by 10 mL of sterile saline injection.
Trial: 30226339
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: 10 mg of 0.5% isobaric bupivacaine plus 15 Âµg of fentanyl injection.